| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10137933 | Resuscitation | 2018 | 32 Pages |
Abstract
The high level evidence supporting the use of antiarrhythmic drugs during CPR for shockable cardiac arrest is limited and showed no benefit for critical outcomes of survival at hospital discharge, survival with favorable neurological function and long-term survival. Future high quality research is needed to confirm these findings and also to evaluate the role of administering antiarrhythmic drugs in children with shockable cardiac arrest, and in adults immediately after ROSC.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Muhammad Usman Ali, Donna Fitzpatrick-Lewis, Meghan Kenny, Parminder Raina, Dianne L. Atkins, Jasmeet Soar, Jerry Nolan, Giuseppe Ristagno, Diana Sherifali,